Overview

Fibrin Sealant VH S/D 500 S-apr in Hepatic Resection

Status:
Completed
Trial end date:
2011-07-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to compare safety and efficacy of Fibrin Sealant (FS) Vapor Heated (VH) S/D 500 s-apr with manual compression as a supportive treatment of local bleeding (i.e. oozing) in hepatic resection surgery when standard surgical techniques are insufficient.
Phase:
Phase 2
Details
Lead Sponsor:
Baxter Healthcare Corporation
Collaborator:
Baxter Innovations GmbH
Treatments:
Fibrin Tissue Adhesive
Hemostatics